![Todd A. Verdoorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Todd A. Verdoorn
Nessuna posizione attualmente
Storia della carriera di Todd A. Verdoorn
Precedenti posizioni note di Todd A. Verdoorn
Società | Posizione | Inizio | Fine |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2016 | 15/11/2019 |
Corporate Officer/Principal | 01/01/2016 | 01/05/2016 | |
Intuitive Quantitation LLC | Corporate Officer/Principal | 01/05/2013 | 01/12/2016 |
NeuroTherapeutics Pharma, Inc.
![]() NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 30/09/2011 | 01/05/2013 |
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Direttore Tecnico/Scientifico/R&S | 20/04/2009 | 01/08/2011 |
Smart Bioscience SAS | Direttore Tecnico/Scientifico/R&S | 01/06/2007 | 01/01/2008 |
Algos Therapeutics, Inc.
![]() Algos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Algos PreClinical Services, Inc. engages in preclinical pain drug development. It specializes in preclinical in vivo pain research and program consulting. The company was founded by Susanne C. Dvorak and Todd C. Verdoorn in 2003 and is headquartered in Roseville, MN. | Direttore operativo | 01/01/2003 | 01/06/2007 |
Direttore Tecnico/Scientifico/R&S | 01/01/2003 | 01/06/2007 | |
Fondatore | 01/01/2003 | 01/06/2007 | |
Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | 01/01/2003 | 01/01/2003 |
Vanderbilt University School of Medicine | Corporate Officer/Principal | - | - |
Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Todd A. Verdoorn
Central College | Undergraduate Degree |
The University of North Carolina at Asheville | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Germania | 2 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Settori
Consumer Services | 6 |
Health Technology | 4 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Aziende private | 6 |
---|---|
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
NeuroTherapeutics Pharma, Inc.
![]() NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Health Technology |
Algos Therapeutics, Inc.
![]() Algos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Algos PreClinical Services, Inc. engages in preclinical pain drug development. It specializes in preclinical in vivo pain research and program consulting. The company was founded by Susanne C. Dvorak and Todd C. Verdoorn in 2003 and is headquartered in Roseville, MN. | Health Technology |
Intuitive Quantitation LLC | |
Smart Bioscience SAS |
- Borsa valori
- Insiders
- Todd A. Verdoorn
- Esperienza